{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:42:27Z","timestamp":1791178947452,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1997,1,1]],"date-time":"1997-01-01T00:00:00Z","timestamp":852076800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[1997,1]]},"DOI":"10.1038\/ng0197-78","type":"journal-article","created":{"date-parts":[[2004,8,18]],"date-time":"2004-08-18T20:19:56Z","timestamp":1092860396000},"page":"78-82","source":"Crossref","is-referenced-by-count":226,"title":["AP2 inhibits cancer cell growth and activates p21WAF1\/CIP1 expression"],"prefix":"10.1038","volume":"15","author":[{"given":"Yi-Xin","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumaravel","family":"Somasundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafik S.","family":"El-Deiry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFng019778_CR1","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/0092-8674(87)90512-5","volume":"50","author":"PJ Mitchell","year":"1987","unstructured":"Mitchell, P.J., Wang, C. & Tjian, R. Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40T antigen. Cell 50, 847\u2013861 (1987).","journal-title":"Cell"},{"key":"BFng019778_CR2","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1101\/gad.2.12a.1557","volume":"2","author":"T Williams","year":"1988","unstructured":"Williams, T., Admon, A., Luscher, B. & Tjian, R. Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements. Genes Dev. 2, 1557\u20131569 (1988).","journal-title":"Genes Dev."},{"key":"BFng019778_CR3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/0092-8674(87)90152-8","volume":"51","author":"M Imagawa","year":"1987","unstructured":"Imagawa, M., Chiu, R. & Karin, M. Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP. Cell 51, 251\u2013260 (1987).","journal-title":"Cell"},{"key":"BFng019778_CR4","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1101\/gad.3.10.1507","volume":"3","author":"B Luscher","year":"1989","unstructured":"Luscher, B., Mitchell, P.J., Williams, T. & Tjian, R. Regulation of transcription factor AP-2 by the morphogen retinoic acid and by second messengers. Genes Dev. 3, 1507\u20131157 (1989).","journal-title":"Genes Dev."},{"key":"BFng019778_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/381235a0","volume":"381","author":"H Schorle","year":"1996","unstructured":"Schorle, H., Meier, P., Buchert, M., Jaenisch, R. & Mitchell, P.J. Transcription factor AP-2 essential for cranial closure and craniofacial development. Nature 381, 235\u2013238 (1996).","journal-title":"Nature"},{"key":"BFng019778_CR6","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/381238a0","volume":"381","author":"J Zhang","year":"1996","unstructured":"Zhang, J. et al. Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2. Nature 381, 238\u2013241 (1996).","journal-title":"Nature"},{"key":"BFng019778_CR7","first-page":"3391","volume":"54","author":"P Michieli","year":"1994","unstructured":"Michieli, P. et al. Induction of WAF1\/CIP1 by a p53-independent pathway. Cancer Res. 54, 3391\u20133395 (1994).","journal-title":"Cancer Res."},{"key":"BFng019778_CR8","first-page":"389","volume":"9","author":"RA Steinman","year":"1994","unstructured":"Steinman, R.A. et al. Induction of p21 (WAF-1\/CIP1) during differentiation. Oncogene. 9, 389\u2013396 (1994).","journal-title":"Oncogene."},{"key":"BFng019778_CR9","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1101\/gad.9.8.935","volume":"9","author":"KF Macleod","year":"1995","unstructured":"Macleod, K.F. et al. p53-dependent and independent expression of p21 during cell growth, differentiation & DNA damage. Genes Dev. 9, 935\u2013944 (1995).","journal-title":"Genes Dev."},{"key":"BFng019778_CR10","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1126\/science.7863327","volume":"267","author":"O Halevy","year":"1995","unstructured":"Halevy, O. et al. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267, 1018\u20131021 (1995).","journal-title":"Science"},{"key":"BFng019778_CR11","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1101\/gad.10.2.142","volume":"10","author":"M Liu","year":"1996","unstructured":"Liu, M., Lee, M.H., Cohen, M., Bommakanti, M. & Freedman, L.P. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocyticcell line U937. Genes Dev. 10, 142\u2013153 (1996).","journal-title":"Genes Dev."},{"key":"BFng019778_CR12","first-page":"2910","volume":"55","author":"WS EL-Deiry","year":"1995","unstructured":"EL-Deiry, W.S. et al. Topological control of P21WAF1\/CIP1 expression in normal and neoplastic tissues. Cancer Res. 55, 2910\u20132919 (1995).","journal-title":"Cancer Res."},{"key":"BFng019778_CR13","first-page":"1557","volume":"12","author":"YX Zeng","year":"1996","unstructured":"Zeng, Y.X. & EL-Deiry, W.S. Regulation of P21WAF1\/CIP1 expression by p53-independent pathways. Oncogene 12, 1557\u20131564 (1996).","journal-title":"Oncogene"},{"key":"BFng019778_CR14","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S0021-9258(17)42193-4","volume":"269","author":"S Kharbanda","year":"1994","unstructured":"Kharbanda, S. et al. Activation of Raf-1 and mitogen-activated protein kinases during monocytic differentiation of human myeloid leukemia cells. J. Biol. Chem. 269, 872\u2013878 (1994).","journal-title":"J. Biol. Chem."},{"key":"BFng019778_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0167-4889(94)00238-A","volume":"1266","author":"EF Sato","year":"1995","unstructured":"Sato, E.F., Edashige, K., Inoue, M. & Utsumi, K. Okadaic acid increased annexin I and induced differentiation of promyelocytic leukemia cells. Biochim. Biophys. Acta. 1266, 23\u201330 (1995).","journal-title":"Biochim. Biophys. Acta."},{"key":"BFng019778_CR16","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1101\/gad.5.4.670","volume":"5","author":"T Williams","year":"1991","unstructured":"Williams, T. & Tjian, R. Analysis of the DNA-binding and activation properties of the transcription factor AP-2. Genes Dev. 5, 670\u2013682 (1991).","journal-title":"Genes Dev."},{"key":"BFng019778_CR17","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1101\/gad.8.11.1258","volume":"8","author":"P Kannan","year":"1994","unstructured":"Kannan, P. et al. N-ras oncogene causes AP-2 transcriptional self-interference, which leads to transformation. Genes Dev. 8, 1258\u20131269 (1994).","journal-title":"Genes Dev."},{"key":"BFng019778_CR18","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/0888-7543(91)90209-W","volume":"10","author":"RB Gaynor","year":"1991","unstructured":"Gaynor, R.B. et al. Localization of the gene for the DNA-binding protein AP-2 to human chromosome 6p22.3-pter. Genomics 10, 1100\u20131102 (1991).","journal-title":"Genomics"},{"key":"BFng019778_CR19","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1126\/science.2300817","volume":"247","author":"JM Trent","year":"1990","unstructured":"Trent, J.M. et al. Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6. Science 247, 568\u201371 (1990).","journal-title":"Science"},{"key":"BFng019778_CR20","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/bjc.1993.101","volume":"67","author":"WD Foulkes","year":"1993","unstructured":"Foulkes, W.D., Ragoussis, J., Stamp, G.W., Allan, G.J. & Trowsdale, J. Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma. Br J. Cancer 67, 551\u20139 (1993).","journal-title":"Br J. Cancer"},{"key":"BFng019778_CR21","first-page":"1152","volume":"54","author":"H Nawroz","year":"1994","unstructured":"Nawroz, H. et al. Allelotype of head and neck aquamous cell carcinoma. Cancer Res. 54, 1152\u20131155 (1994).","journal-title":"Cancer Res."},{"key":"BFng019778_CR22","first-page":"1635","volume":"56","author":"GP Robertson","year":"1996","unstructured":"Robertson, G.P., Coleman, A.B. & Lugo, T.G. Mechanisms of human melanoma cell growth and tumor suppression by chromosome 6. Cancer Res. 56, 1635\u20131641 (1996).","journal-title":"Cancer Res."},{"key":"BFng019778_CR23","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1073\/pnas.93.7.3088","volume":"93","author":"K Somasundaram","year":"1996","unstructured":"Somasundaram, K. et al. Repression of a matrix metalloprotease gene by E1A correlates with its ability to bind to cell type-specific transcription factor AP-2. Proc. Natl. Acad. Sci. USA 93, 3088\u20133093 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng019778_CR24","doi-asserted-by":"publisher","first-page":"4174","DOI":"10.1128\/MCB.13.7.4174","volume":"13","author":"R Buettner","year":"1993","unstructured":"Buettner, R. et al. An alternatively spliced mRNA from the AP-2 gene encodes a negative regulator of transcriptional activation by AP-2. Mol. Cell. Biol. 13, 4174\u20134185 (1993).","journal-title":"Mol. Cell. Biol."},{"key":"BFng019778_CR25","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1101\/gad.9.10.1149","volume":"9","author":"CJ Sherr","year":"1995","unstructured":"Sherr, C.J. & Roberts, J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9, 1149\u20131163 (1995).","journal-title":"Genes Dev."},{"key":"BFng019778_CR26","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1128\/MCB.9.1.321","volume":"9","author":"SE Hyman","year":"1989","unstructured":"Hyman, S.E., Comb, M., Pearlberg, J. & Goodman, H.M. An AP-2 element acts synergistically with the cyclic AMP- and phorbol ester-inducible enhancer of the human proenkephalin gene. Mol. Cell. Biol. 9, 321\u2013324 (1989).","journal-title":"Mol. Cell. Biol."},{"key":"BFng019778_CR27","doi-asserted-by":"publisher","first-page":"24844","DOI":"10.1074\/jbc.270.42.24844","volume":"270","author":"C Duan","year":"1995","unstructured":"Duan, C. & Clemmons, D.R. Transcription factor AP-2 regulates human insulin-like growth factor binding protein-5 gene expression. J. Biol. Chem. 270, 24844\u201324851 (1995).","journal-title":"J. Biol. Chem."},{"key":"BFng019778_CR28","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1073\/pnas.92.3.744","volume":"92","author":"JM Bosher","year":"1995","unstructured":"Bosher, J.M., Williams, T. & Hurst, H.C. The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. Proc. Natl. Acad. Sci. USA 92, 744\u2013747 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng019778_CR29","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1101\/gad.10.7.804","volume":"10","author":"NA Timchenko","year":"1996","unstructured":"Timchenko, N.A., Wilde, M., Nakanishi, M., Smith, J.R. & Darlington, G.J. CCAAT\/enhancer-binding protein a (C\/EBPa) inhibits cell proliferation through the p21 (WAF1\/CIP1\/SDI-1) protein. Genes Dev. 10, 804\u2013815 (1996).","journal-title":"Genes Dev."},{"key":"BFng019778_CR30","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1126\/science.272.5262.719","volume":"272","author":"YE Chin","year":"1996","unstructured":"Chin, Y.E. et al. Cell growth arrest and induction of cyclin dependent kinase inhibitor p21 WAF1\/CIPI mediated by STAT1. Science 272, 719\u2013722 (1996).","journal-title":"Science"},{"key":"BFng019778_CR31","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-P","volume":"75","author":"WS EI-Deiry","year":"1993","unstructured":"EI-Deiry, W.S. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817\u2013825 (1993).","journal-title":"Cell"},{"key":"BFng019778_CR32","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/0092-8674(92)90593-2","volume":"71","author":"MB Kastan","year":"1992","unstructured":"Kastan, M.B. et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71, 587\u2013597 (1992).","journal-title":"Cell"}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ng0197-78","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng0197-78.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng0197-78.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:18:30Z","timestamp":1684441110000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ng0197-78"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1997,1]]}},"alternative-id":["BFng019778"],"URL":"https:\/\/doi.org\/10.1038\/ng0197-78","relation":{},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,1]]}}}